In this episode, I’ll discuss the role for ketamine in status epilepticus. Subscribe on iTunes, Android, or Stitcher The initial therapy for status epilepticus is to use one of the following benzodiazepines: Lorazepam 0.1 mg/kg capped at 4 mg IV Midazolam 0.2 mg/kg capped at 10 mg IM Diazepam 0.15 mg/kg capped at 10 mg IV […]
A free twice-weekly podcast where you can listen to critical care and hospital pharmacy information
Subscribe to the #1 ranked critical care and hospital pharmacy podcast, The Elective Rotation here:
Episode 830: Using Heparin Anti-Xa Levels to Evaluate Apixaban, Rivaroxaban, Fondaparinux, or Danaparoid Levels
In this episode, I’ll discuss using heparin anti-Xa levels to evaluate apixaban, rivaroxaban, fondaparinux, and danaparoid levels. Subscribe on iTunes, Android, or Stitcher Anti-Xa inhibitors such as apixaban, rivaroxaban, fondaparinux, and danaparoid do not have readily available assays, yet there is often a clinical need to determine their presence or absence. Because heparin anti-Xa assays are […]
Episode 829: Three ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome
In this episode, I’ll discuss three ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome. Subscribe on iTunes, Android, or Stitcher Muscular rigidity, significant hyperthermia, and autonomic instability are all common features of serotonin syndrome and neuroleptic malignant syndrome. While these two syndromes are very similar in presentation, they can usually be differentiated by looking […]
Episode 828: A Systematic Review of the Ketorolac Dose Ceiling for ED Analgesia
In this episode, I’ll discuss a systematic review of the ketorolac dose ceiling for ED analgesia. Subscribe on iTunes, Android, or Stitcher Ketorolac is FDA approved for a dose of 30 mg IV for analgesia however there is extensive research dating back as far as 30 years that supports a ceiling dose in the 10 […]
Episode 827: Early vs Late Anticoagulation in Stroke Due to Atrial Fibrillation
In this episode, I’ll discuss early as compared with later initiation of direct oral anticoagulants (DOACs) in patients with atrial fibrillation who have had an acute ischemic stroke. Subscribe on iTunes, Android, or Stitcher How soon to start anticoagulation after stroke due to afib is a matter of significant debate as there is a […]
Episode 826: Just How Bad Are Probiotics in the ICU?
In this episode, I’ll discuss probiotic-associated central venous catheter bloodstream infections in the ICU. Subscribe on iTunes, Android, or Stitcher While probiotics are typically seen as a harmless intervention that may have benefits related to antibiotic-associated diarrhea, bloodstream infections caused by organisms contained within probiotics have been reported in ICU patients. A group of […]
Episode 825: Are We Using the Wrong Definition of Oliguria?
In this episode, I’ll discuss an alternative definition of oliguria. Subscribe on iTunes, Android, or Stitcher The commonly used definition of oliguria is a urine output of 0.5 mL/kg/hr over a 6 hr period. However some small studies have suggested that this definition of oliguria is too liberal. To bring clarity to this clinical […]
Episode 824: Torsemide vs Furosemide – Which Is Better For Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure?
In this episode, I’ll discuss torsemide vs furosemide for symptoms and quality of life among patients hospitalized for heart failure. Subscribe on iTunes, Android, or Stitcher Whether torsemide improves patient Heart Failure (HF) symptoms and quality of life better than furosemide is a matter of debate among clinicians, and a group of authors recently […]
Episode 823: Quantitative Neuromuscular Monitoring To Guide Sugammadex Use
In this episode, I’ll discuss the Management of muscle relaxation with rocuronium and reversal with neostigmine or sugammadex guided by quantitative neuromuscular monitoring. Subscribe on iTunes, Android, or Stitcher Sugammadex is an effective but expensive neuromuscular blocking reversal agent compared with the previous standard of care, neostigmine. In many cases neostigmine will work adequately, […]
Episode 822: How Much IV levothyroxine is Enough for Myxedema Coma?
In this episode, I’ll discuss the dose of IV levothyroxine used for myxedema coma. Subscribe on iTunes, Android, or Stitcher Myxedema coma is a rare medical emergency with in-hospital mortality of ~30% When it occurs, myxedema coma is often a result of either: 1. Withdrawal of thyroid therapy or 2. The first sign of thyroid […]
Episode 821: What dose of inhaled tranexamic acid is used for nonmassive hemoptysis?
In this episode, I’ll discuss the dose of inhaled tranexamic acid used for nonmassive hemoptysis. Subscribe on iTunes, Android, or Stitcher Tranexamic acid (TA) is an antifibrinolytic medication. It forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis. Tranexamic acid is commonly used systemically to reduce bleeding in trauma or […]
Episode 820: In Septic Shock, How Soon Should Hydrocortisone Be Added?
In this episode, I’ll discuss how soon hydrocortisone should be added to patients with septic shock. Subscribe on iTunes, Android, or Stitcher Back in episode 818, I discussed recently published data that suggested a mortality benefit for adding hydrocortisone to patients on norepinephrine for septic shock rather than adding vasopressin. To add to that data, […]
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 81
- Next Page »